Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Far2 | Rat | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | FAR2 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of FAR2 mRNA | CTD | PMID:22079256 | Far2 | Rat | 1,2-dichloroethane | decreases expression | ISO | Far2 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of FAR2 mRNA | CTD | PMID:28189721 and PMID:28960355 | Far2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | FAR2 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of FAR2 mRNA | CTD | PMID:21998131 | Far2 | Rat | 2-palmitoylglycerol | increases expression | ISO | FAR2 (Homo sapiens) | 6480464 | 2-palmitoylglycerol results in increased expression of FAR2 mRNA | CTD | PMID:37199045 | Far2 | Rat | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Far2 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of FAR2 mRNA | CTD | PMID:20188158 | Far2 | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | FAR2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of FAR2 mRNA | CTD | PMID:28628672 | Far2 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | FAR2 (Homo sapiens) | 6480464 | bisphenol S results in increased expression of FAR2 protein | CTD | PMID:34186270 | Far2 | Rat | aflatoxin B1 | increases methylation | ISO | FAR2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of FAR2 intron | CTD | PMID:30157460 | Far2 | Rat | Aflatoxin B2 alpha | increases methylation | ISO | FAR2 (Homo sapiens) | 6480464 | aflatoxin B2 results in increased methylation of FAR2 intron | CTD | PMID:30157460 | Far2 | Rat | all-trans-retinoic acid | increases expression | ISO | FAR2 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of FAR2 mRNA | CTD | PMID:21934132 and PMID:33167477 | Far2 | Rat | all-trans-retinoic acid | decreases expression | ISO | FAR2 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of FAR2 mRNA | CTD | PMID:23724009 | Far2 | Rat | arsenite(3-) | decreases expression | ISO | FAR2 (Homo sapiens) | 6480464 | arsenite results in decreased expression of FAR2 mRNA | CTD | PMID:23974009 | Far2 | Rat | atrazine | affects methylation | EXP | | 6480464 | Atrazine affects the methylation of FAR2 gene | CTD | PMID:35440735 | Far2 | Rat | belinostat | decreases expression | ISO | FAR2 (Homo sapiens) | 6480464 | belinostat results in decreased expression of FAR2 mRNA | CTD | PMID:27188386 | Far2 | Rat | benzo[a]pyrene | decreases expression | ISO | FAR2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of FAR2 mRNA | CTD | PMID:20064835 | Far2 | Rat | benzo[a]pyrene | increases methylation | ISO | FAR2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of FAR2 5' UTR more ... | CTD | PMID:27901495 | Far2 | Rat | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of FAR2 mRNA | CTD | PMID:21839799 | Far2 | Rat | bis(2-ethylhexyl) phthalate | decreases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in decreased expression of FAR2 mRNA | CTD | PMID:36005737 | Far2 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of FAR2 mRNA | CTD | PMID:25181051 | Far2 | Rat | bisphenol A | decreases expression | ISO | Far2 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of FAR2 mRNA | CTD | PMID:32156529 | Far2 | Rat | bisphenol A | increases methylation | ISO | Far2 (Mus musculus) | 6480464 | bisphenol A results in increased methylation of FAR2 promoter | CTD | PMID:27312807 | Far2 | Rat | bisphenol A | multiple interactions | ISO | FAR2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of FAR2 mRNA | CTD | PMID:28628672 | Far2 | Rat | bisphenol F | decreases expression | ISO | Far2 (Mus musculus) | 6480464 | bisphenol F results in decreased expression of FAR2 mRNA | CTD | PMID:38685157 | Far2 | Rat | calcitriol | multiple interactions | ISO | FAR2 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of FAR2 mRNA | CTD | PMID:21592394 | Far2 | Rat | calcitriol | increases expression | ISO | FAR2 (Homo sapiens) | 6480464 | Calcitriol results in increased expression of FAR2 mRNA | CTD | PMID:21592394 | Far2 | Rat | CGP 52608 | multiple interactions | ISO | FAR2 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to FAR2 gene] | CTD | PMID:28238834 | Far2 | Rat | chromium(6+) | affects expression | ISO | FAR2 (Homo sapiens) | 6480464 | chromium hexavalent ion affects the expression of FAR2 mRNA | CTD | PMID:30690063 | Far2 | Rat | cisplatin | decreases expression | ISO | FAR2 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of FAR2 mRNA | CTD | PMID:19561079 and PMID:27594783 | Far2 | Rat | cobalt dichloride | decreases expression | ISO | FAR2 (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of FAR2 mRNA | CTD | PMID:19320972 | Far2 | Rat | copper atom | multiple interactions | ISO | FAR2 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of FAR2 mRNA | CTD | PMID:20971185 | Far2 | Rat | copper(0) | multiple interactions | ISO | FAR2 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of FAR2 mRNA | CTD | PMID:20971185 | Far2 | Rat | dexamethasone | multiple interactions | ISO | FAR2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of FAR2 mRNA | CTD | PMID:28628672 | Far2 | Rat | Dibutyl phosphate | affects expression | ISO | FAR2 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of FAR2 mRNA | CTD | PMID:37042841 | Far2 | Rat | dorsomorphin | multiple interactions | ISO | FAR2 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Far2 | Rat | entinostat | decreases expression | ISO | FAR2 (Homo sapiens) | 6480464 | entinostat results in decreased expression of FAR2 mRNA | CTD | PMID:26272509 | Far2 | Rat | entinostat | multiple interactions | ISO | FAR2 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FAR2 mRNA | CTD | PMID:27188386 | Far2 | Rat | ethyl methanesulfonate | decreases expression | ISO | FAR2 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in decreased expression of FAR2 mRNA | CTD | PMID:23649840 | Far2 | Rat | formaldehyde | decreases expression | ISO | FAR2 (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of FAR2 mRNA | CTD | PMID:23649840 | Far2 | Rat | genistein | decreases expression | ISO | Far2 (Mus musculus) | 6480464 | Genistein results in decreased expression of FAR2 mRNA | CTD | PMID:32186404 | Far2 | Rat | glyphosate | increases methylation | EXP | | 6480464 | Glyphosate results in increased methylation of FAR2 gene | CTD | PMID:31011160 | Far2 | Rat | indole-3-methanol | multiple interactions | EXP | | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of FAR2 mRNA | CTD | PMID:22129741 | Far2 | Rat | indometacin | multiple interactions | ISO | FAR2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of FAR2 mRNA | CTD | PMID:28628672 | Far2 | Rat | isotretinoin | decreases expression | ISO | FAR2 (Homo sapiens) | 6480464 | Isotretinoin results in decreased expression of FAR2 mRNA | CTD | PMID:20436886 | Far2 | Rat | levonorgestrel | multiple interactions | ISO | FAR2 (Homo sapiens) | 6480464 | [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of FAR2 mRNA | CTD | PMID:19074003 | Far2 | Rat | lipopolysaccharide | multiple interactions | ISO | FAR2 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of FAR2 mRNA | CTD | PMID:35811015 | Far2 | Rat | methyl methanesulfonate | decreases expression | ISO | FAR2 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in decreased expression of FAR2 mRNA | CTD | PMID:23649840 | Far2 | Rat | methylmercury chloride | decreases expression | ISO | FAR2 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of FAR2 mRNA | CTD | PMID:23179753 | Far2 | Rat | methylparaben | decreases expression | ISO | FAR2 (Homo sapiens) | 6480464 | methylparaben results in decreased expression of FAR2 mRNA | CTD | PMID:31745603 | Far2 | Rat | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of FAR2 mRNA | CTD | PMID:22129741 | Far2 | Rat | NADP zwitterion | multiple interactions | ISO | FAR2 (Homo sapiens) | 6480464 | NADP binds to and results in increased activity of FAR2 protein | CTD | PMID:25526675 | Far2 | Rat | NADP(+) | multiple interactions | ISO | FAR2 (Homo sapiens) | 6480464 | NADP binds to and results in increased activity of FAR2 protein | CTD | PMID:25526675 | Far2 | Rat | nickel atom | decreases expression | ISO | FAR2 (Homo sapiens) | 6480464 | Nickel results in decreased expression of FAR2 mRNA | CTD | PMID:24768652 | Far2 | Rat | ozone | increases expression | EXP | | 6480464 | Ozone results in increased expression of FAR2 mRNA | CTD | PMID:28623178 | Far2 | Rat | potassium chromate | multiple interactions | ISO | FAR2 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of FAR2 mRNA | CTD | PMID:22079256 | Far2 | Rat | potassium chromate | increases expression | ISO | FAR2 (Homo sapiens) | 6480464 | potassium chromate(VI) results in increased expression of FAR2 mRNA | CTD | PMID:22714537 | Far2 | Rat | potassium chromate | decreases expression | ISO | FAR2 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of FAR2 mRNA | CTD | PMID:22079256 | Far2 | Rat | S-(1,2-dichlorovinyl)-L-cysteine | decreases expression | ISO | FAR2 (Homo sapiens) | 6480464 | S-(1 and 2-dichlorovinyl)cysteine results in decreased expression of FAR2 mRNA | CTD | PMID:35811015 | Far2 | Rat | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | FAR2 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of FAR2 mRNA | CTD | PMID:35811015 | Far2 | Rat | SB 431542 | multiple interactions | ISO | FAR2 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Far2 | Rat | silicon dioxide | decreases expression | ISO | FAR2 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of FAR2 mRNA | CTD | PMID:25895662 | Far2 | Rat | testosterone | multiple interactions | ISO | FAR2 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of FAR2 mRNA | CTD | PMID:21592394 | Far2 | Rat | testosterone | decreases expression | ISO | FAR2 (Homo sapiens) | 6480464 | Testosterone results in decreased expression of FAR2 mRNA | CTD | PMID:21592394 | Far2 | Rat | testosterone undecanoate | multiple interactions | ISO | FAR2 (Homo sapiens) | 6480464 | [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of FAR2 mRNA | CTD | PMID:19074003 | Far2 | Rat | titanium dioxide | decreases methylation | ISO | Far2 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of FAR2 gene | CTD | PMID:35295148 | Far2 | Rat | triclosan | decreases expression | ISO | FAR2 (Homo sapiens) | 6480464 | Triclosan results in decreased expression of FAR2 mRNA | CTD | PMID:30510588 | Far2 | Rat | triphenyl phosphate | affects expression | ISO | FAR2 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of FAR2 mRNA | CTD | PMID:37042841 | Far2 | Rat | triptonide | increases expression | ISO | Far2 (Mus musculus) | 6480464 | triptonide results in increased expression of FAR2 mRNA | CTD | PMID:33045310 | Far2 | Rat | valproic acid | affects expression | ISO | FAR2 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of FAR2 mRNA | CTD | PMID:25979313 | Far2 | Rat | valproic acid | increases expression | ISO | FAR2 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of FAR2 mRNA | CTD | PMID:24383497 and PMID:26272509 | Far2 | Rat | valproic acid | multiple interactions | ISO | FAR2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAR2 mRNA | CTD | PMID:27188386 | Far2 | Rat | valproic acid | decreases expression | ISO | FAR2 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of FAR2 mRNA | CTD | PMID:23179753 and PMID:27188386 | |